generic glp-1 receptor agonists novo nordisk agonist medications Today, we approved the first for an injectable Explore our recent flyer to
Description
Experts say a less expensive version of these GLP-1 medications would give more people access to these effective weight-loss drugs
As an added advantage, GLP-1s are not themselves addictive and don't trigger withdrawal
Jorsal A, Kistorp C, Holmager P, et al
Following liraglutide, exenatide emerged as the second-highest in terms of this association
doi:10.3389/fphar.2023.1102792 Survodutide phase II trial shows 83% of adults treated achieved groundbreaking results in liver disease due to MASH, with significant improvements in fibrosis
Tang S, Ma W, Bai P
